BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
9.33
+0.55 (6.26%)
Aug 7, 2026, 4:00 PM EDT - Market closed
BBOT Market Cap
BBOT has a market cap or net worth of $747.4 million as of August 7, 2026. Its market cap has increased by 221.46% in one year.
Market Cap
747.40M
Enterprise Value
361.15M
1-Year Change
221.46%
Ranking
Category
Stock Price
$9.33
ChartMarket Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $747.40M, an increase of 1,855.90%. That is a compound annual growth rate of 229.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 747.40M | -25.37% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 781.58M |
| Candel Therapeutics | 775.93M |
| Tenax Therapeutics | 769.87M |
| Oculis Holding AG | 762.70M |
| CytomX Therapeutics | 753.25M |
| Rigel Pharmaceuticals | 750.37M |
| Gyre Therapeutics | 743.63M |
| Crescent Biopharma | 720.77M |